COP vs DHR: Which Is the Better Buy?
Side-by-side comparison of ConocoPhillips and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
ConocoPhillips · Energy
$125.78
+7.3% upside to fair value
Grade C
VS
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
QuantHub Verdict
DHR has more upside to fair value
(+13.2%).
COP trades at a lower forward P/E
(21.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
COP |
DHR |
| Current Price |
$125.78 |
$174.04 |
| Fair Value Estimate |
$134.90 |
$197.01 |
| Upside to Fair Value |
+7.3%
|
+13.2%
|
| Market Cap |
$153.3B |
$123.2B |
| Forward P/E |
21.0x
|
33.4x
|
| EV / EBITDA |
7.5x
|
20.3x
|
| Price / Sales |
2.6x
|
5.0x
|
| Price / FCF |
8.4x
|
23.3x
|
| Revenue Growth YoY |
-2.5%
|
+3.7%
|
| Gross Margin |
33.1%
|
60.7%
|
| Operating Margin |
25.4%
|
21.0%
|
| Return on Equity |
11.3%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
11.96%
|
4.3%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
ConocoPhillips is a leading independent oil and gas exploration and production company with a strong focus on low-cost shale assets and sustainability initiatives. The company benefits from a durable competitive position due to its cost advantage and early ESG leadership, but faces near-term earnings pressure as revenue declined 2.5% and earnings fell 23.4% in the most recent quarter year-over-ye…
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Accumulation Zones
| Metric |
COP |
DHR |
| Zone Low |
$101.18 |
$147.76 |
| Zone High |
$114.67 |
$167.46 |
| In Buy Zone? |
No
|
No
|